FBPixel Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells - David Perlmutter M.D.

Science

Study Title
Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells
Publication
Molecular Nutrition and Food Research
Author(s)

John D. Clarke, Anna Hsu, Zhen Yu, Roderick H. Dashwood and Emily Ho

Abstract

Scope:
Sulforaphane (SFN) is an isothiocyanate derived from cruciferous vegetables such as broccoli. The ability of SFN to inhibit histone deacetylase (HDAC) enzymes may be one mechanism by which it acts as a chemoprevention agent. The ability of a chemopreventive agent to specifically cause cytotoxicity in cancer and not normal cells is an important factor in determining its safety and clinical relevance.
Methods and results:
We characterized the effects of SFN in normal (PrEC), benign hyper- plasia (BPH1) and cancerous (LnCap and PC3) prostate epithelial cells. We observed that 15 mM SFN selectively induced cell cycle arrest and apoptosis in BPH1, LnCap and PC3 cells but not PrEC cells. SFN treatment also selectively decreased HDAC activity, and Class I and II HDAC proteins, increased acetylated histone H3 at the promoter for P21, induced p21 expression and increased tubulin acetylation in prostate cancer cells. HDAC6 over-expression was able to reverse SFN-induced cyotoxicity. In PrEC cells, SFN caused only a transient reduction in HDAC activity with no change in any other endpoints tested. The differences in sensitivity to SFN in PrEC and PC3 are likely not due to differences in SFN metabolism or differences in phase 2 enzyme induction.
Conclusion:
SFN exerts differential effects on cell proliferation, HDAC activity and down- stream targets in normal and cancer cells.

Date
December 22, 2010
View study

Share This

Related Topics

SulforaphaneProstate Cancer

Dr. David Perlmutter is on the cutting edge of innovative medicine that looks at all lifestyle influences on health and illness.

Andrew Weil, MD